ArticleJAMA health forum2024

Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans.

Yonghong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.